A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200mg in pregnant women living with HIV
Cheaper HIV treatment for children: a report in The Lancet
First patient enrolled in PediCAP trial
Pablo Rojo & Anna Turkova comment on HIV drug optimisation for adolescents living with HIV
Cascade of care in children and adolescents with HIV in the Russian Federation
Cascade of care in children and adolescents with HIV in Russian Federation
Pediatric dolutegravir (DTG) dosing recommendations derived from combined P1093 and ODYSSEY Population Pharmacokinetic analysis
ORCHESTRA starts to play! A new project to tackle the coronavirus pandemic
Celebrating #WorldAidsDay – Gianni’s ‘Looking for Lydia’ Documentary
WHO Essential Medicines List (EML) New Antibiotic User Guide
European Medicines Agency approves use of Dolutegravir 5 mg dispersible tablet for younger children living with HIV
#WorldAntimicrobialAwarenessWeek: Antimicrobial Stewardship Programs (ASPs)
Tools for Healthcare Workers to measure Health Research Capacity Development at an Individual Level
Irja Lutsar has been elected as Estonia’s Woman of the Year
Louise Hill Presents NeoVanc Sub-study Results at ESPID 2020
RESCEU: Fighting Respiratory Syncytial Virus and its economic impact
